Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung × Radiation Dose Hypofractionation × 90 days × Clear all

NCT04310020 2026-03-17

Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms